Suppr超能文献

非侵入性吲哚菁绿血浆清除率可预测肝移植后早期并发症、移植物失功或死亡。

Noninvasive indocyanine green plasma disappearance rate predicts early complications, graft failure or death after liver transplantation.

机构信息

Department of General Surgery, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg, Germany.

出版信息

Hepatobiliary Pancreat Dis Int. 2011 Aug;10(4):362-8. doi: 10.1016/s1499-3872(11)60061-1.

Abstract

BACKGROUND

Early detection of graft malfunction or postoperative complications is essential to save patients and organs after orthotopic liver transplantation (OLT). Predictive tests for graft dysfunction are needed to enable earlier implementation of organ-saving interventions following transplantation. This study was undertaken to assess the value of indocyanine green plasma disappearance rates (ICG-PDRs) for predicting postoperative complications, graft dysfunction, and patient survival following OLT.

METHODS

Eighty-six patients undergoing OLT were included in this single-centre trial. ICG-PDR was assessed daily for the first 7 days following OLT. Endpoints were graft loss or death within 30 days and postoperative complications, graft loss, or death within 30 days.

RESULTS

Postoperative complications of 31 patients included deaths (12 patients) or graft losses. ICG-PDR was significantly different in patients whose endpoints were graft loss or death beginning from day 3 and in those whose endpoints were graft-loss, death, or postoperative complications beginning from day 4 after OLT. For day 7 measurements, receiver operating characteristic curve analysis revealed an ICG-PDR cut-off for predicting death or graft loss of 9.6% per min (a sensitivity of 75.0%, a specificity of 72.6%, positive predictive value 0.35, negative predictive value 0.94). For prediction of graft loss, death, or postoperative complications, the ICG-PDR cut-off was 12.3% per min (a sensitivity of 68.9%, a specificity of 66.7%, positive predictive value 0.57, negative predictive value 0.77).

CONCLUSIONS

ICG-PDR measurements on postoperative day 7 are predictive of early patient outcomes following OLT. The added value over that of routinely determined laboratory parameters is low.

摘要

背景

原位肝移植(OLT)后,早期发现移植物功能障碍或术后并发症对于挽救患者和器官至关重要。需要预测移植物功能障碍的检测方法,以便在移植后更早地实施保器官干预措施。本研究旨在评估吲哚菁绿血浆清除率(ICG-PDR)在预测 OLT 后术后并发症、移植物功能障碍和患者生存方面的价值。

方法

本单中心试验纳入 86 例行 OLT 的患者。OLT 后第 1 天至第 7 天每天评估 ICG-PDR。终点为 30 天内移植物丢失或死亡以及术后并发症、移植物丢失或死亡。

结果

31 例患者发生术后并发症,包括死亡(12 例)或移植物丢失。OLT 后第 3 天开始,终点为移植物丢失或死亡的患者,以及 OLT 后第 4 天开始,终点为移植物丢失、死亡或术后并发症的患者,其 ICG-PDR 显著不同。对于第 7 天的测量,ROC 曲线分析显示,预测死亡或移植物丢失的 ICG-PDR 截断值为 9.6%/min(敏感性为 75.0%,特异性为 72.6%,阳性预测值为 0.35,阴性预测值为 0.94)。对于预测移植物丢失、死亡或术后并发症,ICG-PDR 截断值为 12.3%/min(敏感性为 68.9%,特异性为 66.7%,阳性预测值为 0.57,阴性预测值为 0.77)。

结论

OLT 后第 7 天的 ICG-PDR 测量值可预测早期患者结局。与常规测定的实验室参数相比,其附加价值较低。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验